Wealth Enhancement Advisory Services »

Keros Therapeutics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $211k 18k 11.80

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Keros Therapeutics

BlackRock
Nantahala Capital Management
AQR Capital Management
Vanguard Capital Management
OrbiMed Advisors
Federated Investors
Vanguard Portfolio Management
Mackenzie Financial
Madison Avenue Partners
Qube Research & Technologies
Jacobs Levy Equity Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Citadel Advisors

View all funds holding Keros Therapeutics